» Articles » PMID: 37228413

Stroke Recurrence is Associated with Unfavorable Intracranial Venous Outflow in Patients with Symptomatic Intracranial Atherosclerotic Large Vessel Severe Stenosis or Occlusion

Overview
Journal Front Neurol
Specialty Neurology
Date 2023 May 25
PMID 37228413
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to investigate the predictive value of intracranial venous outflow for recurrent cerebral ischemic events (RCIE) in patients with symptomatic intracranial atherosclerotic large-vessel severe stenosis or occlusion (sICAS-S/O).

Methods: This retrospective study included sICAS-S/O patients with anterior circulation who underwent dynamic computed tomography angiography (dCTA) and computed tomography perfusion (CTP). Arterial collaterals were evaluated using the pial arterial filling score for dCTA data, tissue-level collaterals (TLC) were assessed using the high-perfusion intensity ratio (HIR, Tmax >10 s/Tmax >6 s), and cortical veins were evaluated using the multi-phase venous score (MVS) for the vein of Labbé (VOL), sphenoparietal sinus (SPS), and superficial cerebral middle vein (SCMV). The relationships between multi-phase venous outflow (mVO), TLC, and 1-year RCIE were analyzed.

Results: Ninety-nine patients were included, 37 of whom had unfavorable mVO (mVO-) and 62 of whom had favorable mVO (mVO+). Compared with the mVO+ patients, mVO- patients had a higher admission National Institutes of Health Stroke Scale (NIHSS) score (median, 4 [interquartile range (IQR), 0-9] vs. 1 [IQR, 0-4];  = 0.048), larger ischemic volume (median, 74.3 [IQR, 10.1-177.9] vs. 20.9 [IQR, 5-86.4] mL;  = 0.042), and worse tissue perfusion (median, 0.04 [IQR, 0-0.17] vs. 0 [IQR, 0-0.03];  = 0.007). Multivariate regression analysis showed that mVO- was an independent predictor of 1-year RCIE.

Conclusion: For patients with sICAS-S/O of the anterior circulation, unfavorable intracranial venous outflow is a potential imaging indicator for predicting higher 1-year RCIE risk.

References
1.
Gao P, Wang T, Wang D, Liebeskind D, Shi H, Li T . Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial. JAMA. 2022; 328(6):534-542. PMC: 9364128. DOI: 10.1001/jama.2022.12000. View

2.
Shi Z, Li J, Zhao M, Zhang M, Wang T, Chen L . Baseline Cerebral Ischemic Core Quantified by Different Automatic Software and Its Predictive Value for Clinical Outcome. Front Neurosci. 2021; 15:608799. PMC: 8072147. DOI: 10.3389/fnins.2021.608799. View

3.
Barnett H, Taylor D, Eliasziw M, Fox A, Ferguson G, Haynes R . Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998; 339(20):1415-25. DOI: 10.1056/NEJM199811123392002. View

4.
Albers G, Lansberg M, Kemp S, Tsai J, Lavori P, Christensen S . A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke. 2017; 12(8):896-905. PMC: 5916787. DOI: 10.1177/1747493017701147. View

5.
Liebeskind D . Collateral circulation. Stroke. 2003; 34(9):2279-84. DOI: 10.1161/01.STR.0000086465.41263.06. View